Everything You Need to Know About Polycystic kidney disease (AD vs AR) for Step 1

Polycystic kidney disease (PKD) is one of those Step 1 topics that looks “renal-only” at first—but it’s really a genetics + path + imaging + complications mashup that shows up everywhere (HTN, hematuria, berry aneurysms, hepatic cysts, neonatal respiratory distress). If you can cleanly separate autosomal dominant PKD (ADPKD) from autosomal recessive PKD (ARPKD)—and know what each one is trying to do to the collecting system—you’ll grab a ton of easy points.

---

Big Picture: ADPKD vs ARPKD (the Step 1 mental model)

The one-liner difference

• ADPKD: Adult disease → cysts in cortex + medulla, enlarged kidneys, berry aneurysms, hepatic cysts.
• ARPKD: Infant/child disease → collecting duct dilation, enlarged echogenic kidneys, congenital hepatic fibrosis, pulmonary hypoplasia risk.

High-yield comparison table

First Aid cross-reference: FA Renal section (cystic diseases) + Neuro (berry aneurysm/subarachnoid hemorrhage) + Cardio (MVP) + GI/hepatobiliary (hepatic cysts, congenital hepatic fibrosis).

---

Definition (what PKD actually is)

Polycystic kidney disease refers to inherited disorders characterized by progressive formation of fluid-filled cysts in the kidneys leading to:

• Enlarged kidneys
• Distortion of renal architecture
• Progressive loss of renal function → CKD/ESRD
• Common associated complications: HTN, hematuria, flank pain, infections, nephrolithiasis

---

Pathophysiology: why do cysts form?

Core concept (very Step 1)

Most inherited cystic kidney diseases are ciliopathies: defects in proteins involved in primary cilia signaling on tubular epithelial cells.

ADPKD (PKD1/PKD2)

• PKD1 (polycystin-1) and PKD2 (polycystin-2) are involved in mechanosensation and Ca²⁺ signaling in tubular epithelial cilia.
• Dysfunction → altered intracellular signaling (including ↑ cAMP effects) → abnormal proliferation + fluid secretion → cyst growth.
• Cysts can arise from multiple nephron segments → widespread cyst burden and massive kidney enlargement.

HY association: PKD1 tends to be more severe/earlier onset than PKD2 (commonly tested concept).

ARPKD (PKHD1)

• PKHD1 → fibrocystin, expressed in collecting ducts and biliary tract.
• Leads to cystic dilation of collecting ducts + congenital hepatic fibrosis (bile duct involvement).
• Severe neonatal disease can reduce urine production in utero → oligohydramnios sequence (Potter sequence).

---

Clinical Presentation (how it shows up on vignettes)

ADPKD: classic Step vignette pattern

Typical patient: adult (30s–50s) with HTN and intermittent hematuria/flank pain.

Common renal findings

• Hypertension (often early)
  • Mechanism: cyst expansion → renal ischemia → ↑ renin → RAAS activation
• Hematuria (gross or microscopic)
• Flank pain/fullness
• Recurrent UTIs (including infected cysts)
• Nephrolithiasis
• Progressive CKD → ESRD

High-yield extrarenal associations

• Berry aneurysms (saccular aneurysms of Circle of Willis) → risk of subarachnoid hemorrhage
  • Clue: “worst headache of my life” in a patient with PKD history
• Hepatic cysts (often asymptomatic; liver function usually preserved)
• Mitral valve prolapse
• Abdominal hernias can occur (less commonly emphasized)

Step-style warning sign:
ADPKD patient with sudden severe headache/meningismus → think ruptured berry aneurysm.

---

ARPKD: infant/child pattern

Typical patient: neonate/infant with enlarged kidneys, renal dysfunction, ± respiratory distress.

Classic findings

• Bilateral enlarged kidneys (may be palpable)
• Renal insufficiency early in life (variable severity)
• Oligohydramnios → Potter sequence in severe cases:
  • Pulmonary hypoplasia → respiratory distress
  • Limb positioning defects, characteristic facies (Potter facies)

Key extrarenal finding

• Congenital hepatic fibrosis → portal hypertension
  • Clues: splenomegaly, varices, thrombocytopenia from hypersplenism (later presentation)

Step-style clue:
Child with cystic kidney disease + signs of portal HTN → strongly favors ARPKD.

---

Diagnosis: what to order and what you’ll see

ADPKD diagnosis

Initial test (often): renal ultrasound

• Multiple bilateral renal cysts
• Enlarged kidneys

CT/MRI

• More sensitive (especially if ultrasound equivocal, or to map cyst burden/complications)

Labs

• Variable early; later shows CKD pattern:
  • ↑ creatinine, ↓ eGFR
  • Mild proteinuria possible
• Urinalysis: hematuria common

When to screen for berry aneurysm? (clinically relevant nuance) Not every PKD patient is routinely imaged in real life. Screening is considered for higher-risk situations (commonly taught):

• Family history of aneurysm/SAH
• High-risk occupations or pre-op planning
• Neurologic symptoms
  Step angle: You’re more likely to be asked to recognize aneurysm complications than to pick screening guidelines—but know the association cold.

---

ARPKD diagnosis

Prenatal ultrasound

• Enlarged, echogenic kidneys
• Oligohydramnios in severe disease

Postnatal ultrasound

• Enlarged kidneys with poor corticomedullary differentiation
• “Cystic” changes often represent dilated collecting ducts (may look more uniformly echogenic than discrete large cysts)

Liver evaluation

• Signs of congenital hepatic fibrosis/portal HTN may prompt liver imaging and labs (but Step focus is association recognition).

---

Treatment: Step 1 high-yield management framework

ADPKD management

1) Control blood pressure

• ACE inhibitor/ARB are typical first-line (RAAS-driven HTN)

2) Slow cyst growth in selected patients

• Tolvaptan (V2 receptor antagonist) can slow progression in some patients
  • Step-relevant concept: ADPKD cyst expansion relates to signaling pathways influenced by cAMP; V2 antagonism decreases cAMP signaling in collecting ducts.

3) Treat complications

• UTIs/cyst infections: antibiotics (sometimes need agents that penetrate cysts)
• Nephrolithiasis management
• Pain control (avoid nephrotoxins if CKD)

4) ESRD management

• Dialysis and kidney transplant

What Step loves: HTN is often early and contributes to progression; treatment is BP control + CKD care.

---

ARPKD management

• Supportive neonatal care (especially respiratory support if pulmonary hypoplasia)
• Manage renal insufficiency and HTN
• Manage portal HTN complications (GI bleeding risk, hypersplenism)
• Dialysis/transplant when indicated (kidney and sometimes liver depending on severity)

---

HY associations & “don’t-miss” Step facts

ADPKD: the high-yield cluster

• PKD1 (chr 16) and PKD2 (chr 4)
• Berry aneurysms → subarachnoid hemorrhage
• Hepatic cysts
• Mitral valve prolapse
• Flank pain + hematuria + HTN in adults
• Progressive CKD

Classic vignette trigger: Adult with HTN and bilateral enlarged kidneys + family history → ADPKD.

---

ARPKD: the high-yield cluster

• PKHD1
• Collecting duct dilation
• Congenital hepatic fibrosis → portal HTN
• Severe disease → oligohydramnios → Potter sequence → pulmonary hypoplasia

Classic vignette trigger: Newborn with respiratory distress + enlarged kidneys + oligohydramnios history.

---

Quick “AD vs AR” question stems (practice-ready)

If you see this… think ADPKD

• “35-year-old with uncontrolled HTN and intermittent gross hematuria”
• “Bilateral enlarged kidneys with multiple cysts; mother had kidney failure”
• “Sudden severe headache in patient with renal cystic disease”

If you see this… think ARPKD

• “Newborn with respiratory distress, oligohydramnios, enlarged kidneys”
• “Child with cystic kidneys and portal hypertension/splenomegaly”

---

First Aid-style memory anchors (clean and testable)

• ADPKD: Adult + Aneurysms + Associated hepatic cysts
• ARPKD: AR = Airway risk (pulmonary hypoplasia) + Abnormal liver (congenital hepatic fibrosis)

---

Rapid review table (last-minute cram)